Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Glucophage 850mg tablets
0601022B0BBABAD
|
Glucophage | Metformin hydrochloride | Endocrine System | 972 |
|
Mediven active class 2 (23-32mmHg) below knee closed toe
21270001239
|
Mediven active class 2 (23-32mmHg) below knee closed toe | Lymphoedema Garments | Appliances | 970 |
|
Uriplan sterile leg bag 38cm inlet tube 750ml
22500505050
|
Uriplan sterile leg bag 38cm inlet tube 750ml | Leg Bags | Incontinence Appliances | 970 |
|
Nicardipine 30mg capsules
0206020Q0AAABAB
|
Nicardipine hydrochloride | Nicardipine hydrochloride | Cardiovascular System | 968 |
|
OxyContin 30mg modified-release tablets
0407020ADBCAHAR
|
OxyContin | Oxycodone hydrochloride | Central Nervous System | 968 |
|
M-M-RVAXPRO vacc inj 0.5ml pre-filled syringes
1404000W0BIAAAD
|
M-M-RVAXPRO | Measles, mumps and rubella vaccine | Immunological Products and Vaccines | 967 |
|
Aciferol D3 400unit tablets
0906040G0CHAAEL
|
Aciferol D3 | Colecalciferol | Nutrition and Blood | 966 |
|
Dansac GX-tra Seals 30mm
23850708511
|
Dansac GX-tra Seals 30mm | Skin Protectors | Stoma Appliances | 966 |
|
Movelat Relief gel
1003020W0BBADAA
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 966 |
|
Avenor 25micrograms/dose / 250micrograms/dose inhaler
0302000N0BPACBG
|
Avenor | Fluticasone propionate (Inhalation) | Respiratory System | 965 |
|
Biatain Non-Adhesive dressing 5cm x 7cm rectangular
20030600173
|
Biatain Non-Adhesive dressing 5cm x 7cm rectangular | Wound Management & Other Dressings | Dressings | 965 |
|
CellCept 250mg capsules
0802010M0BBAAAA
|
CellCept | Mycophenolate mofetil | Malignant Disease and Immunosuppression | 965 |
|
Clear Advantage Spirit sheath style 1 standard 28mm
22303953120
|
Clear Advantage Spirit sheath style 1 standard 28mm | Incontinence Sheaths | Incontinence Appliances | 965 |
|
Colistimethate 1million unit pdr for neb soln ud vials
0501070I0AAADAD
|
Colistimeth sodium (Systemic) | Colistimethate sodium | Infections | 965 |
|
Levomepromazine 6mg tablets
0402010K0AAAMAM
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | 965 |
|
Pro-Cal powder
0913141F0BBAAAA
|
Pro-Cal powder 6.7 kcal/g energy and protein fortifier | Powder 6.7 kcal/g energy and protein fortifier (0913141) | Nutrition and Blood | 965 |
|
Bactroban 2% cream
1310011M0BBABAB
|
Bactroban (Topical) | Mupirocin | Skin | 964 |
|
Fortisip Compact Starter Pack liquid
0913011V0BDABAF
|
Fortisip ready to serve 2.4 kcal/ml milkshake lower volume | Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 964 |
|
SunVit-D3 5,000unit tablets
0906040G0BWAFCN
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | 964 |
|
Welland Aura ileostomy bag maxi 13-60/80mm beige
23605606291
|
Welland Aura ileostomy bag maxi 13-60/80mm beige | Ileostomy Bags | Stoma Appliances | 964 |
|
Libra GB2 non-drainable night drainage bag
22602086000
|
Libra GB2 non-drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | 963 |
|
Perampanel 500micrograms/ml oral suspension sugar free
0408010AKAAAJAJ
|
Perampanel | Perampanel | Central Nervous System | 963 |
|
Biatain Silicone dressing 15cm x 19cm sacral
20030900353
|
Biatain Silicone dressing 15cm x 19cm sacral | Wound Management & Other Dressings | Dressings | 962 |
|
Buscopan 20mg/1ml solution for injection ampoules
0102000N0BBABAA
|
Buscopan | Hyoscine butylbromide | Gastro-Intestinal System | 962 |
|
Diprosone 0.05% ointment
1304000D0BBACBA
|
Diprosone | Betamethasone esters | Skin | 962 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.